While a previous study had found that extracorporeal CPR outperformed conventional CPR among patients with out-of-hospital cardiac arrest, a newer analysis suggests the two treatment options result in similar outcomes. 

The device, designed to be worn for up to 24 hours at a time, uses ultrasound technology and artificial intelligence to track how much blood the user's heart is pumping.

The findings stem from a new CDC study comparing people who received the new booster and those who received between two to four doses of the original vaccine.

A team of specialists out of Cedars-Sinai developed the deep learning model using TTEs from nearly 3,000 patients.

In this new video, pediatric cardiologists discuss some of the long-term issues associated with multisystem inflammatory syndrome in children (MIS-C), a rare disease linked to COVID-19.

A multidisciplinary center dedicated to early detection of cancer in ostensibly healthy individuals has demonstrated the soundness of its founding concept, cost-effectively catching cancers of many kinds before the onset of symptoms.

The new recall includes nearly 4,500 devices. There have been 134 incidents so far, including 5 adverse events.  

It is still early for this new-look TAVR valve, but initial findings out of China include a procedural success rate of 100% and no deaths, disabling strokes or myocardial infarctions after 30 days. Read a full analysis from the team using the device.